ArticleCell biology and toxicology2026
EGR1/miR-4306/MAT2A axis aggravates pyroptosis and extracellular matrix degradation of nucleus pulposus cells in intervertebral disc degeneration.
Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundIntervertebral disc degeneration (IVDD) acts as the prerequisite and pathological basis for a series of spinal degenerative diseases, and it remains one of the most harmful and difficult-to-treat conditions in this category. However, the exact pathogenesis of IVDD has not been fully elucidated.
methodsComprehensive analysis of data mining, bioinformatics and real-time quantitative PCR was used to pinpoint the key transcription factors participated in the progression of IVDD. The role of early growth response factor 1 (EGR1) in IVDD was determined through a series of loss- and gain-of-function experiments in vitro and in vivo. Mechanistically, bioinformatics, chromatin immunoprecipitation, and dual-luciferase reporter assays were applied to illustrate the interaction mechanism between microRNA-4306 (miR-4306) and Methionine adenosyltransferase 2A (MAT2A), or EGR1. Finally, rescue experiments were designed to assess the impact of the EGR1/miR-4306/MAT2A axis on nucleus pulposus cell function in vitro.
resultsEGR1 was highly expressed in degenerated nucleus pulposus tissues and lipopolysaccharide-induced nucleus pulposus cells, and expression levels of EGR1 were positively relevant with IVDD pathological grade. EGR1 overexpression aggravated lipopolysaccharide-induced pyroptosis and extracellular matrix degradation of nucleus pulposus cells, while EGR1 knockdown inhibited these effects in vitro and alleviated IVDD progression in mice in vivo. Mechanistically, EGR1 directly suppressed miR-4306 transcription by binding its promoter, and MAT2A was a target gene of miR-4306. Rescue experiments confirmed EGR1 knockdown inhibited lipopolysaccharide-induced nucleus pulposus cells damage by mediating the miR-4306/MAT2A axis.
conclusionThis study suggested the EGR1/miR-4306/MAT2A axis played an important role in IVDD pathogenesis, which might be promising therapeutic targets for IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.